Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Red Cat | RCAT | Apr 26, 2024 | 1.39 | -4.79 |
Red River Bancshares | RRBI | Apr 26, 2024 | 47.21 | +3.42 |
Red Robin Gourmet Burgers | RRGB | Apr 26, 2024 | 7.01 | +1.59 |
Red Rock Resorts A | RRR | Apr 26, 2024 | 54.12 | -8.63 |
Red Violet | RDVT | Apr 26, 2024 | 16.99 | +0.06 |
RDDT | Apr 26, 2024 | 45.43 | 0.00 | |
Redfin | RDFN | Apr 26, 2024 | 5.62 | +8.49 |
RedHill Biopharma ADR | RDHL | Apr 26, 2024 | 0.43 | +2.82 |
Redwire | RDW | Apr 26, 2024 | 3.96 | +2.86 |
Redwood Trust | RWT-A | Apr 26, 2024 | 24.45 | -0.14 |
Redwood Trust | RWT | Apr 26, 2024 | 5.72 | +0.88 |
Redwoods Acquisition | RWOD | Apr 26, 2024 | 7.42 | +22.24 |
Regal Rexnord | RRX | Apr 26, 2024 | 164.11 | +1.32 |
Regency Centers | REG | Apr 26, 2024 | 58.28 | -1.32 |
Regency Centers A Pref | REGCP | Apr 26, 2024 | 23.02 | +0.88 |
Regency Centers B Pref | REGCO | Apr 26, 2024 | 22.11 | -1.82 |
Regeneron Pharmaceuticals | REGN | Apr 26, 2024 | 883.20 | -0.84 |
REGENXBIO | RGNX | Apr 26, 2024 | 16.19 | +0.81 |
Regional Health Properties | RHE | Apr 26, 2024 | 2.96 | -1.33 |
Regional Health Properties A Pref | RHE-A | Apr 26, 2024 | 0.85 | 0.00 |
Regional Management | RM | Apr 26, 2024 | 26.42 | +0.61 |
Regions Financial | RF | Apr 26, 2024 | 19.62 | +0.05 |
Regions Financial B Pref | RF-B | Apr 26, 2024 | 24.75 | -0.32 |
Regions Financial C Pref | RF-C | Apr 26, 2024 | 21.94 | +0.60 |
Regions Financial E Pref | RF-E | Apr 26, 2024 | 17.42 | -0.76 |
Regis | RGS | Apr 26, 2024 | 5.65 | +1.62 |
Regulus Therapeutics | RGLS | Apr 26, 2024 | 2.42 | +6.61 |
Reinsurance Group of America | RGA | Apr 26, 2024 | 188.78 | -1.19 |
REIT Index ETF Vanguard | VNQ | Apr 26, 2024 | 80.16 | +0.05 |
Rekor Systems | REKR | Apr 26, 2024 | 1.79 | +2.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.